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Summary The cytotoxic effects of chemotherapeutic drugs on quiescent and actively proliferating cells of a
Lewis lung carcinoma (LLTC) cell line have been examined. The sensitivities of cells in plateau-phase and
exponentially growing cultures were compared with those of cells recovered from large subcutaneous tumours
both immediately after tumour disaggregation and after one or 4 days in culture. Flow cytometric analysis
indicated that when cells freshly prepared from tumours were placed into culture, they underwent extensive
recruitment into S-phase. Several drugs were less cytotoxic towards both plateau-phase cultured cells and cells
freshly isolated from tumours than they were against exponentially growing cells. These included amsacrine,
its 4-methyl-5-(N-methyl)carboxamide derivative CI-921, doxorubicin, and nitrogen mustard. In contrast to
these drugs, chlorambucil and plasma from cyclophosphamide-treated mice did not show decreased activity
against slowly proliferating cells from cultures or tumours relative to cells in an actively proliferating state.
The similar sensitivities of plateau-phase cultured cells and cells taken directly from large growing tumours is
direct evidence that plateau-phase cultures are a useful approximation to the state of cytokinetic resistance to
chemotherapeutic drugs that prevails in solid tumours, although they may not fully reflect the cytokinetic
heterogeneity present in tumours.
Mammalian cells of both neoplastic and normal origin are
more sensitive to most anticancer agents when actively
progressing through the cell cycle than when they enter a
non-cycling state (van Putten, 1974; Valeriote & van Putten,
1975; Tannock, 1978). Such cycle selectivity may limit the
chemotherapeutic sensitivity of solid tumours, many of
which contain a high proportion of non-cycling tumour cells
(Steel, 1977; Tannock, 1978). A deeper understanding of the
relationship between proliferative activity and drug sensi-
tivity is needed to clarify the importance of this selectivity
in vivo.
Since Bruce and his associates (reviewed by Valeriote &
van Putten, 1975; van Putten, 1974) first demonstrated the
importance of proliferative state in relation to drug
sensitivity in vivo, most studies have utilized in vitro models
of non-cycling cells such as plateau-phase cultures (Barranco
& Novak, 1974; Drewinko et al., 1981; Hahn & Little, 1972;
Twentyman & Bleehen, 1975) and multicellular spheroids
(Sutherland & Durand, 1984; Nederman & Twentyman,
1984; Kwok & Twentyman, 1985). The question remains as
to whether these provide adequate models for non-cycling
cells in tumours (Valeriote & van Putten, 1975; Twentyman
& Bleehen, 1975). In the work described here a novel and
complementary approach has been adopted by investigating
changes in drug sensitivity in short-term primary cultures
derived from an advanced murine solid tumour. These
cultures initially contain high proportions of cells which have
entered a non-cycling state in the tumour, and are then
recruited into cycle by growth in culture at low density. The
attendant changes in drug sensitivity are compared with
those accompanying the progression of exponential-phase
cultures into plateau-phase.
Important differences in drug sensitivity between cycling
and non-cycling cells have been demonstrated with antimeta-
bolites, alkylating agents and DNA intercalating drugs
(Barranco & Novak, 1974; Drewinko et al., 1981; Kwok &
Twentyman, 1985; Twentyman & Bleehen, 1975). The
present study focuses on 4-methyl-5-(N-methyl)carboxamide-
amsacrine (CI-921), a new 9-anilinoacridine derivative which
has recently entered phase I clinical trials (Baguley et al.,
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1984). This intercalating agent is an analogue of the anti-
leukaemic drug amsacrine, but shows higher activity against
a variety of solid tumours in mice including the Lewis lung
(LL) carcinoma (Baguley et al., 1984).
The marked cycle selectivity of amsacrine has been
demonstrated in several experimental systems (Drewinko et
al., 1981; Wilson et al., 1981a,b), and its lack of activity
against non-cycling cells has been suggested as a reason for
its failure to act against solid tumours (Wilson et al.,
1981a,b). It was thus of interest to determine whether the
improved activity of CI-921 against a solid tumour is a
consequence of a reduced resistance of non-cycling cells to
this agent. This paper also describes the cycle selectivity of
another clinical intercalating agent, doxorubicin, and that of
three alkylating agents of the nitrogen mustard class
(nitrogen mustard, cyclophosphamide and chlorambucil).
The cell line studied is a Lewis lung carcinoma subline,
designated LLTC, which has been adapted to growth in
vitro. When inoculated s.c. into mice, the resulting tumours
demonstrate a low growth fraction, and are markedly less
drug-sensitive than the parent transplanted Lewis lung line
(Baguley et al., 1986). The present study seeks to evaluate
the contribution of cytokinetic factors to this resistance, as
well as providing a comparison of the drug sensitivities of
tumour cells which enter a non-cycling state in either an in
vitro or an in vivo environment.
Materials and methods
Materials
Cytotoxic drugs used in this study, and their sources, are
amsacrine and CI-921 (Warner-Lambert Co., Ann Arbor,
Michigan, USA), doxorubicin (Pharmitalia, Italy), nitrogen
mustard (Boots Co., Notts., UK), chlorambucil (Warner-
Lambert Co.), and cyclophosphamide (Bristol, Crows Nest,
NSW, Australia). Colchicine was obtained from
Commonwealth Serum Laboratories, Melbourne, Australia,
[5-Me-3H]-thymidine from Amersham, England, diamidino-
phenylindole from Sigma, USA, methylene blue from Ajax
Chemicals, Australia, and pronase from Calbiochem, USA.
Activated cyclophosphamide was prepared by the method of
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Begg et al. (1985). Briefly, cyclophosphamide in saline was
inoculated i.p. into B6D2F1 mice (60mgml-1, 0.2ml per
mouse). After 20min, treated and control mice were ether-
anaesthetized, and blood collected by exsanguination into
heparinized pipettes. Plasma was recovered by centrifugation
(13,000g for 3min), diluted to 10% v/v in alpha-modified
minimal essential medium (MEM), filter-sterilized (0.2Mm
pore size), rapidly frozen and stored at -70°C for use 1 and
2 days later.
Tumour cells
A Lewis lung tissue culture (LLTC) line, developed from the
Lewis lung tumour at the Southern Research Institute,
Birmingham, Alabama, USA, (Wilkoff et al., 1980) was
obtained from Dr R.C. Jackson (Warner-Lambert Company,
Ann Arbor, Michigan, USA) in 1981. LLTC cells were
cultured in 25cm2 plastic flasks using growth medium
(GM) consisting of alpha-modified MEM supplemented with
foetal bovine serum (FBS, Smith Biolab, New Zealand) and
antibiotics (penicillin 100Uml-1, streptomycin 100 gml-1).
In early experiments cells were cultured in FBS at 10% (V/v);
this was later reduced to 5% (Figure 4 and subsequent
clonogenicity assays). In order to propagate LLTC cells for
injection into B6D2F1 mice, cultures were established at 104
cellsml-1 in 100mm dishes containing GM (15ml). Cells
were grown to at least 1.5 x 107/dish, removed from the
plastic using trypsin (0.1%, Difco) in citrate saline (trisodium
citrate dihydrate 4.4g1-1, KC1 10g1-1, pH7.3), collected by
centrifugation, and 106 cells (0.1 ml) injected s.c.
Exponential andplateau-phase LLTC cultures
LLTC cultures (1 ml) were initiated in 24-well culture dishes
in GM at densities ranging from 104 to 3 x 105 cellsml-1.
After growth at 37°C in a CO2 incubator for 66h the cell
density, proliferative activity, clonogenicity and drug
sensitivity of these cultures were assessed. The 24-well dishes
were placed on a temperature block to maintain the cultures
at 35-37°C during subsequent manipulations. Culture
medium (0.5ml) was discarded from each well, and replaced
with 0.5ml of fresh, prewarmed GM containing amsacrine
(final concentration SpM), [3H]-thymidine (2MCiml-1) or
colchicine (1 Mgml-1) as required. The dishes were then
incubated at 37°C on a grid submerged in a waterbath,
under an atmosphere of 5% CO2 in air maintained by
flushing the gas mixture through a dome over the cultures at
a rate of 81min-1. After one hour (2h in the case of
colchicine treatment) the cultures were washed with PBS
(NaCl 8g1-1, KCI 0.2g1-1, anhydrous Na2HP04 1.15gl-1,
anhydrous KH2PO4 0.2gl-1, CaCl2 0.1gl-1, MgCl.6H2O
0.1 g -1, pH7.4) and trypsinized. Cell densities were
determined with a Coulter counter, and clonogenicity was
assessed by plating known numbers of cells (102-104) in GM
(5ml) in 60mm tissue culture dishes. After growth for 10
days, colonies were fixed and stained in methylene blue
(0.5% w/v in 50% aqueous ethanol). Colonies containing
more than 100 cells were counted.
The mitotic index was determined by pooling the PBS
wash and trypsinized cells from colchicine-treated cultures,
collecting the cells by centrifugation and dropping
hypotonically-swollen (0.075M KCI, 37°C, 6min) cells on to
microscope slides after fixation with Carnoy's fixative
(methanol:acetic acid, 3:1, v/v) at 0°C. Slides were stained
with Gurr Giemsa stain, and 2000 cells scored for mitotic
figures for each culture.
Incorporation of [3H]-thymidine into acid-insoluble
material was determined by precipitation of PBS-washed
cells with an equal volume of 10% trichloroacetic acid.
Precipitates were collected on Whatman GF/C glass fibre
filters, washed with 1 M HCI, dried and counted in a toluene-
based scintillation fluid in a Beckman model LS 8000 liquid
scintillation spectrometer.
Survival curves for one hour exposures of LLTC to
cytotoxic drugs were determined using the above methods,
with cultures being initiated at 104 cellsml-l and 3x105
cellsml-1 to provide (after 66h) exponential and plateau-
phase cultures respectively. Three exponential phase cultures
were pooled at each time point after drug treatment to
provide sufficient numbers of cells. Alternatively, survival of
exponential- and plateau-phase cells in culture was
investigated by initiating cultures at 105 cellsml-1 in 100mm
dishes containing 15ml GM. After 1 (exponential-phase) or
4 (plateau-phase) days cultures were trypsinized, the cells
collected by centrifugation, and exposed to cytotoxic drugs
in polystyrene tubes (105 cellsml-1) at 37°C for 1 h. Cells
were then collected by centrifugation, washed twice,
resuspended in GM and clonogenicity was determined as
above.
Tumour disaggregation
Mice were killed by cervical dislocation and the tumours
excised and minced using crossed scalpels. The mince was
placed in a glass vessel containing a small spin bar and
incubated with stirring in GM (60mg tumour mince ml-')
containing pronase (1 mgml-1) at 37°C for 40min. At the
conclusion of the digestion, large aggregates were allowed to
settle, most of the supernatant was removed, the cells
recovered by centrifugation, and washed once with GM.
Large, refractile cells.were counted using a haemocytometer.
Recoveries were 1-2 x 108 cells g'-I tumour.
Cell culture and cytotoxicity assays with cellsfrom tumours
LLTC cells obtained from tumours had different growth
requirements from LLTC cells maintained continuously in
culture, in that they required reduced °2 concentrations and
high cell densities (or irradiated feeders). Freshly prepared
tumour cell suspensions were cultured for one or 4 days by
seeding at 105 or 104 cellsml-l respectively and growing in
an atmosphere of 5% 02 and 5% CO2 in nitrogen. Drug
sensitivity was evaluated by exposing single cell suspensions
(pronase digests of tumours or trypsinized day 1 or day 4
cultures) for 1 h in polystyrene tubes as above. Clonogenicity
was determined by a modification of a previously described
technique (Courtenay, 1976) in which colonies were grown
on the substrate in 60mm dishes in liquid culture, rather
than in agar. 102-105 cells were plated in each dish with
lethally irradiated (35Gy, Cobalt-60) LLTC cells added as
feeders to maintain a constant cell number of 105 cells/dish.
After growth in an atmosphere of 5% 02 and 5% CO2 for
10 days, colonies were stained with methylene blue and
counted as above.
Flow cytometry
Flow cytometry was performed as described previously
(Baguley et al., 1984) using the method of Taylor (1980).
Tumours were disaggregated with pronase as above, but the
cell suspension was washed twice. Cell suspensions (106ml-1)
were permeabilized by addition of an equal volume of 0.8%
Triton X in PBS containing diamidinophenylindole
(2Mgml-1). The distribution of DNA contents was
determined with an Ortho Instruments Model ICP 22A
analyser, using pigeon erythrocytes as an internal DNA
standard. Proportions of cells in different cell cycle phases
were estimated by drawing symmetrical curves over the Gl-
and G2-phase peaks and measuring areas.
Results
Exponential andplateau-phase LLTC cells
Initial experiments were designed to characterize exponential
and plateau-phase LLTC cultures and to assess their
sensitivity to amsacrine and CI-921. Seeding at high cell
densities (3 x lO5ml-1) provided plateau-phase culturesCYTOKINETIC RESISTANCE OF CELLS FROM TUMOURS 757
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Figure 1 Proliferative activity of LLTC cultures. Cultures were
initiated in 24-well dishes at the cell densities indicated and
harvested after 66h. Panel a: x, +, cellsml-1; 0, mitotic index
(mitotic figures as a percentage of total cells after a 2h
accumulation in colchicine before trypsinization); 0, *,
incorporation of [3H]-TdR into TCA-insoluble material during a
60min exposure before trypsinization. Pairs of symbols refer to
separate experiments. Panel b: Clonogenic assay of LLTC.
Plating efficiency of untreated cells: 0, El. Plating efficiency
after treatment with amsacrine (5yM) for 60min immediately
before trypsinization (-) or immediately after trypsinization and
resuspension in GM to 10 cellsml - (0). In this and subsequent
figures, vertical bars are standard errors from replicate colony
counts.
within 66h (Figure la). These cultures showed markedly
reduced proliferative activity relative to exponentially
growing cultures as demonstrated by a decreased mitotic
index and rate of [3H]-thymidine incorporation (Figure la).
As estimated by flow cytometry, -90% of cells in plateau-
phase cultures (66h after seeding at 3 x 105cellsml-1) had a
Gl-phase DNA content, while in exponential cultures
(seeded at 104cellsml-1) these cells represented only 50% of
the total (Figure 2).
No significant change in the clonogenic potential of LLTC
cells was observed on entry into plateau-phase, while
sensitivity to amsacrine was greatly reduced (Figure lb).
Essentially identical results were obtained whether cells were
a
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Figure 2 DNA content by flow cytometry of logarithmic phase
(top panel) and plateau-phase (lower panel) LLTC cultures,
seeded at 104 and 3 x 105 cellsml-1 respectively 66h previously.
The vertical line indicates the position of the internal standard
(pigeon erythrocytes).
exposed to amsacrine in intact monolayers, or after
trypsinization and resuspension in fresh medium at low
density (Figure lb). Thus amsacrine resistance in plateau-
phase cultures reflects a stable adaptive change, presumably
related to the observed cytokinetic changes, rather than
reflecting changing environmental conditions such as
nutrient depletion, low pH or high cell density per se.
The relative sensitivities of exponential and plateau-phase
LLTC cultures to amsacrine and CI-921 were compared
using 1 h treatments at a range of drug concentrations
(Figure 3). CI-921 was the more potent of the two drugs,
and provided survival curves with less pronounced curvature
than did amsacrine. However, both drugs displayed similar
selectivity for exponential phase cells, with D37 ratios
(plateau/exponential) of 3.1 and 4.0 for amsacrine, and 3.8
and 3.1 for CI-921 in two independent experiments.
The effects of CI-921 and three other cytotoxic agents
against exponential and plateau-phase LLTC cultures were
also evaluated by exposing trypsinized single-cell suspensions
to a range of drug concentrations. CI-921 again
demonstrated much greater activity against exponential-
phase cultures, as did doxorubicin and nitrogen mustard
(Figure 4, panels a-c). In contrast, chlorambucil was
equally active against cells from both exponential and
plateau-phase cultures (Figure 4, panel d).
Loss ofresistance to CI-921 during culture ofLLTC cells
explantedfrom advanced tumours
The effect of amsacrine and CI-921 on the clonogenicity of
LLTC cells was investigated immediately after preparing cells
from a subcutaneous tumour and also after growing these
cells for 1 to 4 days in culture (Figures 5a,b).
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Figure 3 Survival curves for 60min exposure of exponentially
growing (0) and plateau-phase (0) LLTC cultures to amsacrine
(Panel a) or CI-921 (Panel b). Cultures were initiated at 104 and
3 x105 cellsml-1. After 66h incubation, cells were exposed to
cytotoxic agents for one hour prior to trypsinization. Surviving
fractions are normalized with respect to control plating
efficiencies which were in the range 64-70%.
Cells prepared freshly from a tumour contained a
substantial proportion of cells (- 10%) highly resistant to
amsacrine and CI-921. However, if cells were first cultured
for 1 day and then treated with either drug, the surviving
fraction decreased by up to one hundredfold. It is unlikely
that such sensitivity is due to cumulative damage resulting
from pronase and trypsin treatments one day apart, as an
even greater increase in sensitivity was observed when the
cells were established at a lower density and cultured for 4
days prior to amsacrine or CI-921 exposure (Figure 5a,b).
This large increase in sensitivity was accompanied by an
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altered cell cycle distribution. The proportion of cells with a
greater than G1 phase DNA content was determined by flow
cytometry, and found to increase from 30% at the time of
extirpation to over 60% after 1 day in culture (Figure 6) and
50% after 4 days.
Effect oftumour size on sensitivity ofcells to CI-921
To investigate whether cells undergo changes in sensitivity to
CI-921 during tumour growth, LLTC cells (106 per mouse)
were inoculated s.c. into B6D2F1 mice either 29 or 20 days
prior to sacrifice. Two 29-day tumours (0.99 and 0.94g) and
two 20-day tumours (0.09 and 0.27g) were excised and
disaggregated. Cell suspensions derived from the two smaller
tumours were more sensitive than those from the larger
tumours at each of the three CI-921 concentrations tested
(Figure 7). Thus as tumour size increases, cells encounter
changing environmental conditions which cause them to
become progressively more refractory to CI-921. However,
differences in the cell cycle distribution of the single cell
suspensions from these tumours were not detectable by flow
cytometry analysis (data not shown).
Effect ofexplant ofLLTC cells on responsiveness to clinical
antitumour drugs
The sensitivity of LLTC cells (both freshly isolated from s.c.
tumours and cultured for 1 day or 4 days after isolation) to
four clinical agents was also investigated. The cytotoxicity of
doxorubicin was found to increase in a manner very similar
to that of CI-921 (Figure Sc): as with amsacrine and CI-921,
cells cultured for 4 days acquired a greater sensitivity than
those cultured for 1 day. Three alkylating agents of the
nitrogen mustard class were also examined. A clear
difference in the cytotoxicity towards freshly prepared and
subsequently cultured tumour cells was observed for nitrogen
mustard (Figure 8a). In contrast to this, chlorambucil
(Figure 8b) and activated cyclophosphamide (Figure 8c)
showed no such discrimination.
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Figure 4 Response ofexponentially growing (0) and plateau-phase (0) LLTC cells to cytotoxic drugs. Cultures were initiated in
100mm dishes at 105 cellsml-1, cells harvested one or 4 days later, and exposed for 60min to a: CI-921; b: doxorubicin; c:
nitrogen mustard; d: chlorambucil.CYTOKINETIC RESISTANCE OF CELLS FROM TUMOURS 759
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Figure 5 Cytotoxicity of intercalating drugs for LLTC cells recovered from advanced s.c. tumours. Cells were exposed for one
hour to amsacrine (a), CI-921 (b) and doxorubicin (c) either immediately after preparation from a tumour (0), or after culture for
one day from 105 cellsml - (/\), or after culture for 4 days from 104 cellsml- (C1).
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Figure 6 DNA content by flow cytometry of LLTC cells freshly
prepared from a s.c. tumour (top panel) and the same cells one
day after initiating cultures at 105 cellsml- . The vertical line
indicates the position of the internal standard, and the
arrowhead the position of the diploid host cell peak.
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Figure 7 Effect of tumour size on sensitivity of cells to CI-921.
LLTC cells freshly prepared from s.c. tumours were exposed to
the indicated concentrations of CI-921 for one hour, and the
clonogenic fraction remaining determined. Tumour sizes were
0.09g (0), 0.27g (0).0.94g (A) andO.99g(A).
Discussion
This study has made use of two complementary approaches
to investigate the relationship between cytokinetic activity
and drug sensitivity in a subline of the Lewis lung
carcinoma, LLTC. The first approach, a comparison of the
drug sensitivity of exponential and plateau-phase cultures, is
similar to many studies which have documented the relative
resistance of plateau-phase cultures to a variety of cytotoxic
agents. The second approach investigates changes in drug
sensitivity under conditions where LLTC cells which have
entered a non-cycling state in advanced tumours are
recruited into cycle in culture.
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Figure 8 Cytotoxicity of alkylating drugs for LLTC cells recovered from advanced subcutaneous tumours. Cells were exposed for
one hour to nitrogen mustard (a), chlorambucil (b), and plasma from cyclophosphamide-treated mice (c) immediately after
preparation from a subcutaneous tumour (0), or after culture for one day from 105 cellsml-I (A\), or after culture for 4 days
from 104 cellsml-1 (El). Concentration is given in gM (a,b), or in per cent (v/v) plasma from cyclophosphamide-treated mice (c).
Cultured LLTC cells
Initial studies with the in vitro passaged cell line demonstrate
that in unfed plateau-phase cultures most LLTC cells enter a
non-cycling state (Figures la, 2) in which they become
resistant to amsacrine (Figure lb). This loss of sensitivity is
not a consequence of environmental conditions in plateau-
phase cultures since similar results were obtained on dilution
of cells into fresh medium at low cell density immediately
before drug exposure (Figure lb) and is in agreement with
similar studies with V79 (Wilson et al., 198la,b) or CHO
Chinese hamster fibroblasts (Sullivan et al., 1986) and LoVo
human colon carcinoma cells (Drewinko et al., 1981).
Exponential and plateau-phase LLTC cultures were also
used to compare the sensitivites of cycling and non-cycling
LLTC cells to the amsacrine analogue CI-921, a new anilino-
acridine antitumour drug with high therapeutic activity
against Lewis lung tumours (Baguley et al., 1984). The
relative inactivity of amsacrine against solid tumours has
been suggested to result, at least in part, from its lack of
activity against non-cycling cells (Wilson et al., 198la,b).
Although CI-921 was more cytotoxic than amsacrine at
equivalent doses against both exponential and plateau-phase
LLTC cells, the differential was similar for both agents
(Figure 3). Thus the therapeutic superiority of the new
amsacrine analogue against Lewis lung tumours does not
appear to reflect a lack of discrimination between cycling
and non-cycling cells.
One difficulty in the use of LLTC cells for these
experiments appears to be the variability in sensitivity to CI-
921 of exponentially growing cultures (e.g., compare Figures
3b and 4a). Such variability probably arises from the use of
different concentrations of FBS for culturing the cells (see
Materials and methods), and from genetic drift, as the
cultures were initiated from separate cryopreserved stocks.
The variability is not a consequence of the different culture
times used in the experiments (66h versus 1 day; experiments
not shown). In any case, although the D37 values in Figures
3b and 4a differ, the relevant point is that the D37 ratios
for cycling and non-cycling cells are similar.
The other intercalating agent studied, doxorubicin, also
shows higher activity against exponential than against
plateau-phase cultures (Figure 4b), as has been demonstrated
with EMT6 (Twentyman & Bleehen, 1975; Kwok &
Twentyman, 1985), CHO (Barranco & Novak, 1974), L1210
(Bhuyan et al., 1977) and LoVo (Drewinko et al., 1981) cells.
Such cycle selectivity of intercalating drugs appears to reflect
the activity of topoisomerase II, which declines in non-
cycling cells (Sullivan et al., 1986).
As examples of a different class of cytotoxic drug two
alkylating agents, nitrogen mustard and chlorambucil, have
been examined. Byfield and Calabro-Jones (1981) suggested
that alkylating agents show selectivity for cycling cells if they
are transported into cells by carrier-dependent mechanisms
with diminished activity in non-cycling cells. Nitrogen
mustard appears to be an example since it is taken up by
cells via the choline transport system (Goldenberg et al.,
1971; Goldenberg & Sinha, 1973), the activity of which may
decline in non-cycling cells (Goldenberg & Begleiter, 1980).
Similarly, cell proliferation-dependent uptake and cyto-
toxicity of melphalan have been described (Blosmanis et al.,
1987). We have shown that nitrogen mustard is selectively
toxic to exponential-phase LLTC cultures (Figure 4c), as
previously reported for EMT6 cells (Twentyman & Bleehen,
1975; Kwok & Twentyman, 1985). In contrast chlorambucil,
which probably enters cells passively (Goldenberg &
Begleiter, 1980) is equally active against exponential and
plateau-phase LLTC (Figure 4d).
LLTC cellsfrom tumours
The LLTC cell line possesses several features which make it
ideally suited for investigating the drug resistance of cells
which enter a non-cycling state in solid tumours. Firstly,
subcutaneous tumours of the LLTC line, contain a high
proportion of cells arrested in GI/Go phase. Such tumours
have a lower growth fraction than the parent Lewis lung
tumour (Baguley et al., 1986, see also Figure 6). Secondly,
LLTC tumours are dissociated by pronase digestion to give
excellent single cell suspensions in high yield (1-2 x 108
cellsg-1). The median volume of these large tumour cellsCYTOKINETIC RESISTANCE OF CELLS FROM TUMOURS 761
was measured at 2.25pl by Coulter pulse height analysis
(data not shown), implying a packed cell density of about
4x 108 cellsg-1. Since histological examination of these
tumours revealed many blood-filled sinusoids and areas of
necrosis, the above cell yields imply that a high proportion
of viable tumour cells are recovered. Thirdly, high plating
efficiencies are obtained (mean plating efficiency 58%, range
36-84%). The properties of high recovery and plating
efficiency give confidence that all major populations in the
tumour are represented in the survival curve data.
Cells from either rapidly growing tumours or non-
proliferating plateau-phase cultures possess populations
(some 1-10% of the cells) which are resistant to amsacrine,
CI-921, and doxorubicin at concentrations of 15, 10 and
5gM respectively (compare Figures 3, 4a, b with Figures 5, 7).
Such resistance is apparent even in cells from the smallest
tumours investigated (0.1 g nodules), and becomes more
pronounced as tumour size increases (Figure 7) presumably
due to intensification of growth-limiting conditions, although
cytokinetic differences between tumours of different size
could not be detected by flow cytometry means.
The relative sensitivities of cells from tumours before and
after culture are similar to the relative sensitivities of
quiescent and cycling cells maintained solely in vitro. When
cells from either plateau-phase cultures or tumours are
cultured under conditions permitting growth, they undergo a
large increase in sensitivity to intercalating drugs (Figures
3,4a and b, 5), and to nitrogen mustard (Figures 4c,8a). In
neither case is there an increase in sensitivity to chlorambucil
(Figures 4d, 8b). Moreover, Begg et al. (1985) described
conditions under which plateau-phase and proliferating cells
in culture are equally sensitive to activated cyclophos-
phamide, a finding which appears to be true also for
tumour-derived cells before and after culture (Figure 8c).
When cells from tumours are cultured, they are recruited
into cycle over the first day with a considerable degree of
synchrony, as evinced by the high proportion of S+G2-
phase cells (Figure 6). When such cells are cultured at a 10-
fold lower density, and incubated for four days, they are also
in an exponentially growing state, but have lost synchrony.
Thus their flow cytometric profile is like that for
exponentially-growing LLTC cells passaged in vitro (see
Figure 2a). Under these conditions, the cells are more
sensitive to intercalators (Figure 5) and nitrogen mustard
(Figure 8a) than after one day in culture. It must be
concluded that (a) the rapid acquisition of drug sensitivity
which develops in tumour-derived cells cultured for one day
is not a simple consequence of either cell cycle synchroniza-
tion or protease-mediated cell damage, as the sensitivity con-
tinues to develop over several days; (b) tumour-derived
cells are heterogeneous with respect to the rate at which
they acquire sensitivity to intercalators (Figure 5). Thus cells
cultured for 4 days not only manifest reduced survival at
all drug concentrations relative to the 1 day cultures, but
the survival curves show much less curvature, indicating the
disappearance ofminor, resistant subpopulations. Indeed, the
survival curves of tumour-derived cells cultured for 4 days
are of a similar shape (simple exponential) to those of
cells released into proliferation by subculture of plateau-
phase cultures (Figure 4a,b). This indicates that cells from
tumours manifest a heterogeneity of kinetics of re-entry into
cell cycle which is not modelled by subculturing the homo-
geneous populations constituting early plateau-phase cultures.
In summary, plateau-phase cultures contain cells broadly
like those recovered from subcutaneous tumours, although
the former may not take account of numerically minor (but
potentially, therapeutically important) populations present in
the latter.
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